Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS
· Delayed Price · Currency is USD
29.45
+0.89 (3.11%)
Aug 13, 2025, 11:10 AM EDT
TKPHF Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 13, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 46,168 | 45,074 | 43,399 | 50,869 | 44,662 | 56,329 | Upgrade
|
| Market Cap Growth | 17.72% | 3.86% | -14.68% | 13.90% | -20.71% | 17.61% | Upgrade
|
| Enterprise Value | 77,932 | 78,050 | 75,918 | 81,755 | 74,563 | 98,218 | Upgrade
|
| Last Close Price | 29.45 | 30.72 | 27.18 | 31.28 | 28.14 | 34.93 | Upgrade
|
| PE Ratio | 48.65 | 62.54 | 45.57 | 21.33 | 23.57 | 16.57 | Upgrade
|
| PS Ratio | 1.49 | 1.47 | 1.54 | 1.68 | 1.52 | 1.95 | Upgrade
|
| PB Ratio | 0.97 | 0.97 | 0.90 | 1.06 | 0.95 | 1.20 | Upgrade
|
| P/FCF Ratio | 7.31 | 7.88 | 12.14 | 8.08 | 5.42 | 6.92 | Upgrade
|
| P/OCF Ratio | 6.04 | 6.39 | 9.16 | 6.92 | 4.83 | 6.16 | Upgrade
|
| EV/Sales Ratio | 2.57 | 2.55 | 2.69 | 2.70 | 2.54 | 3.40 | Upgrade
|
| EV/EBITDA Ratio | 9.09 | 9.48 | 10.04 | 8.46 | 7.65 | 11.04 | Upgrade
|
| EV/EBIT Ratio | 20.72 | 20.76 | 22.99 | 17.54 | 15.09 | 25.62 | Upgrade
|
| EV/FCF Ratio | 12.34 | 13.65 | 21.23 | 12.99 | 9.06 | 12.07 | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | Upgrade
|
| Debt / EBITDA Ratio | 3.97 | 3.96 | 4.57 | 3.79 | 4.07 | 5.16 | Upgrade
|
| Debt / FCF Ratio | 5.53 | 5.94 | 10.10 | 5.81 | 4.81 | 5.64 | Upgrade
|
| Asset Turnover | 0.30 | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | Upgrade
|
| Inventory Turnover | 1.25 | 1.30 | 1.30 | 1.36 | 1.40 | 1.34 | Upgrade
|
| Quick Ratio | 0.48 | 0.44 | 0.50 | 0.49 | 0.73 | 1.00 | Upgrade
|
| Current Ratio | 1.16 | 1.01 | 1.11 | 0.97 | 1.21 | 1.53 | Upgrade
|
| Return on Equity (ROE) | 1.87% | 1.52% | 2.12% | 5.27% | 4.24% | 7.60% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 2.40% | 2.15% | 2.85% | 2.88% | 2.06% | Upgrade
|
| Return on Capital (ROIC) | 2.71% | 2.84% | 2.61% | 3.57% | 3.62% | 2.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 4.80% | 3.90% | 5.40% | 5.40% | 3.80% | Upgrade
|
| Earnings Yield | 2.06% | 1.60% | 2.20% | 4.69% | 4.24% | 6.04% | Upgrade
|
| FCF Yield | 13.68% | 12.69% | 8.24% | 12.37% | 18.44% | 14.44% | Upgrade
|
| Dividend Yield | 4.52% | 4.26% | 4.57% | 4.33% | 5.27% | 4.66% | Upgrade
|
| Payout Ratio | 226.17% | 280.28% | 199.34% | 88.14% | 123.30% | 75.36% | Upgrade
|
| Buyback Yield / Dilution | -1.18% | -1.58% | -0.67% | 0.46% | -0.23% | -0.47% | Upgrade
|
| Total Shareholder Return | 3.33% | 2.68% | 3.91% | 4.79% | 5.04% | 4.19% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.